ANTIGEN RAPID TEST

SARS-COV-2 (FLUORESCENCE IMMUNOCHROMATOGRAPHY)

SARS-CoV-2-Antigen-Rapid-Test-Kit-2.jpg

COVID-19 RAPID TEST CASSETTE

The World Health Organization (WHO) on March 11 declared COVID-19 a pandemic, pointing to the over 4 million cases of the corona virus illness in over 110 countries and territories around the world and the sustained risk of further global spread. To stop further global spread of the virus, the world needs a screening test that is fast and reliable. We started to develop a rapid test cassette against the COVID-19.

HOUGH Pharma is proud to announce that we are one of the first companies with a rapid test for COVID-19 IgG/IgM. Our product is made with FDA/CE/TGA mark in order to to fulfill highest USA/European/Australian standards . Now worldwide our product is being used to screen patients for the coronavirus.

Sensitivity

SENSITIVITY CHART

Serial

Number 

Days from

Onset

Number of Antigen

Postive Samples

Sensitivity

1

0-3

27

93.10%(95CI:77.23%~99.15%)

2

4-7

33

100%(95CI:89.42%~100.00%)

Total

 ⩽7

60

96.77%(95CI:88.83%~99.61%)

  • Sample source: The samples were collected from 62 patients covid-19 confirmed by PCR

Specificity

SPECIFICITY CHART

No.

Number of Antigen Negative Samples

Total Number

of Samples

Specificity

1

186

188

98.9%(95CI:96.21%~99.87%)

  • Sample source: The 188 samples were confirmed negative by PCR.

Comparison of the Detection Rate

COMPARISON OF THE DETECTION RATE OF DIFFERENT SAMPLES

COVID-19

Patients 

Nucleic Acid Detection in

Nasopharyngeal Swab

Antigen Detection

in Serum

Specificity

62

60.78%

96.77%

100%

© 2020 Hough Pharma